Decade-long use of the antimicrobial peptide combination tyrothricin does not pose a major risk of acquired resistance with gram-positive bacteria and Candida spp
Publisher: Govi-Verlag
ISSN: 0031-7144
Source: Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.69, Iss.11, 2014-11, pp. : 838-841
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ketolides tackle Gram-positive resistance
Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. :